|
:''This article is about the biotech corporation. For the style fly tying, see Fly lure''. For the heteropteran bugs, see Corixidae. Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana. The name Corixa comes from the true bug (Insecta: Hemiptera: Heteroptera) genus ''Corixa'' (family Corixidae, Water boatman), described by Geoffroy, in 1762. On 12 July 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa. GSK had formerly made use of the Corixa's MPL (''Monophosphoryl lipid A'', a derivative of the lipid A molecule), an adjuvant in some of their vaccines. On 31 March 2006, Corixa's doors closed after over 11 years in business. ==External links== * 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Corixa (company)」の詳細全文を読む スポンサード リンク
|